Eli Lilly and Company (LLY) fell 13.40 percent to $646.35 on Thursday after releasing disappointing second-quarter results.
Revenue dropped to 3.82 billion euros, while total comprehensive loss widened to 12.86 billion euros from 2.61 billion euros a year ago.
The stock opened at $675.66 and traded between $633.20 and $678.29, with volume spiking to 22.7 million shares compared to an average of 3.7 million on the New York Stock Exchange. Shares hit a new 52-week low during the session, down sharply from the year's high of $972.53.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.